AKESF 股价走势图
AKESF 股票价格预测
Akeso, Inc.
$11.13
-8.3%
$-1
收盘价：Sep 02, 16:00:00 GMT-4
$11.5
3.32%
$0.36
盘后：Sep 02, 19:53:02 GMT-4
返回
Akeso, Inc. (AKESF) 股票价格预测
关键数据
前收盘价
$12.13
开盘价
$11.5
当日区间
$11.19 - $11.5
52周范围
$10.5 - $21.35
交易量
300
平均成交量
1.5K
股息收益率
--
每股收益（TTM）
-0.16
市值
$10.5B
什么是 AKESO INC.？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
